Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif

Journal of Biological Chemistry

Volumn 289, Issue 13, 2014, Pages 8839-8851

  Jehle, Katja ^a   Cato, Laura ^b   Neeb, Antje ^a   Muhle Goll, Claudia ^c   Jung, Nicole ^c   Smith, Emmanuel W ^d   Buzon, Victor ^e   Carbó, Laia R ^e   Esteb́anez Perpiñ́a, Eva ^e   Schmitz, Katja ^f   Fruk, Ljiljana ^c   Luy, Burkhard ^c   Chen, Yu ^d   Cox, Marc B ^g   Bras̈e, Stefan ^a,c   Brown, Myles ^b   Cato, Andrew C B ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF BARCELONA   (Spain)

^f DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINO ACIDS; CHEMICAL ACTIVATION; LIGANDS;

ALLOSTERIC MODULATORS; ANDROGEN RECEPTORS; ANDROGEN-DEPENDENT; LIGAND BINDING DOMAIN; PROSTATE CANCERS; RECEPTOR BINDING; REGULATORY SEQUENCES; TRANSCRIPTOME ANALYSIS;

BIOACTIVITY;

ANDROGEN; ANDROGEN RECEPTOR; CHAPERONE; PROTEIN BAG 1L; UNCLASSIFIED DRUG; BCL2-ASSOCIATED ATHANOGENE 1 PROTEIN; DNA BINDING PROTEIN; OLIGOPEPTIDE; PROTEIN BINDING; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING FUNCTION 3; BINDING SITE; CHROMATIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; REGULATORY MECHANISM; ALLOSTERISM; CELL LINE; CHEMISTRY; GENETICS; METABOLISM; MUTATION; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION;

ALLOSTERIC REGULATION; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL LINE; DNA-BINDING PROTEINS; HUMANS; MUTATION; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; REPETITIVE SEQUENCES, AMINO ACID; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84897403211     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.534859     Document Type: Article

References (71)

1. Matsumoto, T., Sakari, M., Okada, M., Yokoyama, A., Takahashi, S., Kouzmenko, A., and Kato, S. (2013) The androgen receptor in health and disease. Annu. Rev. Physiol. 75, 201-224
2. Waltering, K. K., Urbanucci, A., and Visakorpi, T. (2012) Androgen receptor (AR) aberrations in castration-resistant prostate cancer. Mol. Cell Endocrinol. 360, 38-43
3. Itkonen, H., and Mills, I. G. (2012) Chromatin binding by the androgen receptor in prostate cancer. Mol. Cell Endocrinol. 360, 44-51
4. Claessens, F., Denayer, S., Van Tilborgh, N., Kerkhofs, S., Helsen, C., and Haelens, A. (2008) Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl. Recept. Signal. 6, e008
5. Heery, D. M., Kalkhoven, E., Hoare, S., and Parker, M. G. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736 (Pubitemid 27270617)
6. Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., and Milburn, M. V (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137-143 (Pubitemid 28425645)
7. Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., and Yamamoto, K. R. (1998) Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356 (Pubitemid 28520983)
8. Dubbink, H. J., Hersmus, R., Verma, C. S., van der Korput, H. A., Berrevoets, C. A., van Tol, J., Ziel-van der Made, A. C., Brinkmann, A. O., Pike, A. C., and Trapman, J. (2004) Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol. Endocrinol. 18, 2132-2150 (Pubitemid 39215246)
9. He, B., Gampe, R. T., Jr., Kole, A. J., Hnat, A. T., Stanley, T. B., An, G., Stewart, E. L., Kalman, R. I., Minges, J. T., and Wilson, E. M. (2004) Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell 16, 425-438 (Pubitemid 39504796)
10. 2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275, 22986-22994
11. Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., and Fletterick, R. J. (2004) Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol. 2, E274
12. Dehm, S. M., and Tindall, D. J. (2007) Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol. Endocrinol. 21, 2855-2863 (Pubitemid 350223500)
13. Estébanez-Perpiñá, E., Arnold, A. A., Nguyen, P., Rodrigues, E. D., Mar, E., Bateman, R., Pallai, P., Shokat, K. M., Baxter, J. D., Guy, R. K., Webb, P., and Fletterick, R. J. (2007) A surface on the androgen receptor that allosterically regulates coactivator binding. Proc. Natl. Acad. Sci. U.S.A. 104, 16074-16079 (Pubitemid 350099366)
14. Yang, X., Chernenko, G., Hao, Y., Ding, Z., Pater, M. M., Pater, A., and Tang, S. C. (1998) Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene 17, 981-989 (Pubitemid 28425408)
15. Takayama, S., Krajewski, S., Krajewska, M., Kitada, S., Zapata, J. M., Kochel, K., Knee, D., Scudiero, D., Tudor, G., Miller, G. J., Miyashita, T., Yamada, M., and Reed, J. C. (1998) Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 58, 3116-3131 (Pubitemid 28335096)
16. Brehmer, D., Rüdiger, S., Gässler, C. S., Klostermeier, D., Packschies, L., Reinstein, J., Mayer, M. P., and Bukau, B. (2001) Tuning of chaperone activity of Hsp70 proteins by modulation of nucleotide exchange. Nat. Struct. Biol. 8, 427-432 (Pubitemid 32381290)
17. Sondermann, H., Scheufler, C., Schneider, C., Hohfeld, J., Hartl, F. U., and Moarefi, I. (2001) Structure of a Bag/Hsc70 complex: convergent functional evolution of Hsp70 nucleotide exchange factors. Science 291, 1553-1557 (Pubitemid 32179223)
18. Townsend, P. A., Stephanou, A., Packham, G., and Latchman, D. S. (2005) BAG-1: a multi-functional pro-survival molecule. Int. J. Biochem. Cell Biol. 37, 251-259 (Pubitemid 39330185)
19. Da Costa, C. R., Villadiego, J., Sancho, R., Fontana, X., Packham, G., Nateri, A. S., and Behrens, A. (2010) Bag1-L is a phosphorylation-dependent coactivator of c-Jun during neuronal apoptosis. Mol. Cell Biol. 30, 3842-3852
20. Guzey, M., Takayama, S., and Reed, J. C. (2000) BAG1L enhances transactivation function of the vitamin D receptor. J. Biol. Chem. 275, 40749-40756 (Pubitemid 32054893)
21. 2-terminal region of the receptor. Mol. Cell Biol. 23, 7189-7197
22. Froesch, B. A., Takayama, S., and Reed, J. C. (1998) BAG-1L protein enhances androgen receptor function. J. Biol. Chem. 273, 11660-11666 (Pubitemid 28272067)
23. Knee, D. A., Froesch, B. A., Nuber, U., Takayama, S., and Reed, J. C. (2001) Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity. J. Biol. Chem. 276, 12718-12724
24. Briknarová, K., Takayama, S., Brive, L., Havert, M. L., Knee, D. A., Velasco, J., Homma, S., Cabezas, E., Stuart, J., Hoyt, D. W., Satterthwait, A. C., Llinás, M., Reed, J. C., and Ely, K. R. (2001) Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein. Nat. Struct. Biol. 8, 349-352 (Pubitemid 32275022)
25. Ghadessy, F. J., Lim, J., Abdullah, A. A., Panet-Raymond, V., Choo, C. K., Lumbroso, R., Tut, T. G., Gottlieb, B., Pinsky, L., Trifiro, M. A., and Yong, E. L. (1999) Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J. Clin. Invest. 103, 1517-1525
26. Schneikert, J., Hübner, S., Martin, E., and Cato, A. C. (1999) A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity. J. Cell Biol. 146, 929-940 (Pubitemid 29430437)
27. Schorpp, M., Jäger, R., Schellander, K., Schenkel, J., Wagner, E. F., Weiher, H., and Angel, P. (1996) The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24, 1787-1788 (Pubitemid 26137941)
28. Carey, M., Leatherwood, J., and Ptashne, M. (1990) A potent GAL4 derivative activates transcription at a distance in vitro. Science 247, 710-712
29. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U., and Speed, T. P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264
30. Dai, M., Wang, P., Boyd, A. D., Kostov, G., Athey, B., Jones, E. G., Bunney, W. E., Myers, R. M., Speed, T. P., Akil, H., Watson, S. J., and Meng, F. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175
31. Smyth, G. K. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3
32. Mink, S., Haenig, B., and Klempnauer, K. H. (1997) Interaction and functional collaboration of p300 and C/EBPβ. Mol. Cell Biol. 17, 6609-6617 (Pubitemid 27451207)
33. Maddalo, D., Neeb, A., Jehle, K., Schmitz, K., Muhle-goll, C., Shatkina, L., Walther, T. V., Bruchmann, A., Gopal, S. M., Wenzel, W., Ulrich, A. S., and Cato, A. C. B. (2012) A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell death. PLoS One 7, 1-14
34. Xu, J., Sankaran, V. G., Ni, M., Menne, T. F., Puram, R. V., Kim, W., and Orkin, S. H. (2010) Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 24, 783-798
35. Xu, K., Wu, Z. J., Groner, A. C., He, H. H., Cai, C., Lis, R. T., Wu, X., Stack, E. C., Loda, M., Liu, T., Xu, H., Cato, L., Thornton, J. E., Gregory, R. I., Morrissey, C., Vessella, R. L., Montironi, R., Magi-Galluzzi, C., Kantoff, P. W., Balk, S. P., Liu, X. S., and Brown, M. (2012) EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338, 1465-1469
36. Crocoll, A., Blum, M., and Cato, A. C. (2000) Isoform-specific expression of BAG-1 in mouse development. Mech. Dev. 91, 355-359 (Pubitemid 30125938)
37. Ni, M., Chen, Y., Fei, T., Li, D., Lim, E., Liu, X. S., and Brown, M. (2013) Amplitude modulation of androgen signaling by c-MYC. Genes Dev. 27, 734-748
38. Munuganti, R. S., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Singh, K., Hassona, M. D., Lack, N. A., Li, H., Ban, F., Tomlinson Guns, E., Young, R., Rennie, P. S., and Cherkasov, A. (2013) Targeting the binding function 3 (BF3) site of the androgen receptor through virtual screening. 2. Development of 2-((2-phenoxyethyl)thio)-1H-benzimidazole derivatives. J. Med. Chem. 56, 1136-1148
39. Shi, A., Huang, L., Lu, C., He, F., and Li, X. (2011) Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors. Bioorg. Med. Chem. 19, 2298-2305
40. Lorber, D. M., and Shoichet, B. K. (1998) Flexible ligand docking using conformational ensembles. Protein Sci. 7, 938-950 (Pubitemid 28216535)
41. Meng, E. C., Gschwend, D. A., Blaney, J. M., and Kuntz, I. D. (1993) Orientational sampling and rigid-body minimization in molecular docking. Proteins 17, 266-278 (Pubitemid 23331457)
42. Takahashi, N., Sasaki, R., Takahashi, J., Takayama, S., Reed, J. C., and Andoh, T. (2001) BAG-1M, an isoform of Bcl-2-interacting protein BAG-1, enhances gene expression driven by CMV promoter. Biochem. Biophys. Res. Commun. 286, 807-814 (Pubitemid 32912959)
43. Söderberg, O., Leuchowius, K. J., Gullberg, M., Jarvius, M., Weibrecht, I., Larsson, L. G., and Landegren, U. (2008) Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45, 227-232
44. Makkonen, H., Kauhanen, M., Paakinaho, V., Jääskeläinen, T., and Palvimo, J. J. (2009) Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res. 37, 4135-4148
45. Geisberg, J. V., and Struhl, K. (2004) Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. Nucleic Acids Res. 32, e151
46. Estébanez-Perpiñá, E., Moore, J. M., Mar, E., Delgado-Rodrigues, E., Nguyen, P., Baxter, J. D., Buehrer, B. M., Webb, P., Fletterick, R. J., and Guy, R. K. (2005) The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. J. Biol. Chem. 280, 8060-8068 (Pubitemid 40349704)
47. Hsu, C. L., Chen, Y. L., Yeh, S., Ting, H. J., Hu, Y. C., Lin, H., Wang, X., and Chang, C. (2003) The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. J. Biol. Chem. 278, 23691-23698 (Pubitemid 36830192)
48. Caboni, L., and Lloyd, D. G. (2013) Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors. Med. Res. Rev. 33, 1081-1118
49. Grosdidier, S., Carbó, L. R., Buzón, V., Brooke, G., Nguyen, P., Baxter, J. D., Bevan, C., Webb, P., Estébanez- Perpiñá, E., and Fernández-Recio, J. (2012) Allosteric conversation in the androgen receptor ligand-binding domain surfaces. Mol. Endocrinol. 26, 1078-1090
50. Buzón, V., Carbó, L. R., Estruch, S. B., Fletterick, R. J., and Estébanez-Perpiñá, E. (2012) A conserved surface on the ligand binding domain of nuclear receptors for allosteric control. Mol. Cell Endocrinol. 348, 394-402
51. Frank, R. (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports: principles and applications. J. Immunol. Methods 267, 13-26
52. Takeshita, Y., Fujinaga, R., Zhao, C., Yanai, A., and Shinoda, K. (2006) Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis. Hum. Mol. Genet. 15, 2298-2312 (Pubitemid 44288676)
53. Yeh, S., and Chang, C. (1996) Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. U.S.A. 93, 5517-5521
54. Lee, S. R., Ramos, S. M., Ko, A., Masiello, D., Swanson, K. D., Lu, M. L., and Balk, S. P. (2002) AR and ER interaction with a p21-activated kinase (PAK6). Mol. Endocrinol. 16, 85-99 (Pubitemid 34044500)
55. Lee, S. S., Crabb, S. J., Janghra, N., Carlberg, C., Williams, A. C., Cutress, R. I., Packham, G., and Hague, A. (2007) Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes. Implications for oral carcinogenesis. Exp. Cell Res. 313, 3222-3238 (Pubitemid 47284061)
56. Chang, Cy., Norris, J. D., Grøn, H., Paige, L. A., Hamilton, P. T., Kenan, D. J., Fowlkes, D., and McDonnell, D. P. (1999) Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries. Discovery of peptide antagonists of estrogen receptors α and β. Mol. Cell Biol. 19, 8226-8239
57. Alen, P., Claessens, F., Verhoeven, G., Rombauts, W., and Peeters, B. (1999) The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell Biol. 19, 6085-6097 (Pubitemid 29399314)
58. Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., and Parker, M. G. (1999) The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol. Cell Biol. 19, 8383-8392 (Pubitemid 30414032)
59. Christiaens, V., Bevan, C. L., Callewaert, L., Haelens, A., Verrijdt, G., Rombauts, W., and Claessens, F. (2002) Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control. J. Biol. Chem. 277, 49230-49237 (Pubitemid 36014352)
60. Jin, F., Claessens, F., and Fondell, J. D. (2012) Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif. J. Biol. Chem. 287, 858-870
61. De Leon, J. T., Iwai, A., Feau, C., Garcia, Y., Balsiger, H. A., Storer, C. L., Suro, R. M., Garza, K. M., Lee, S., Kim, Y. S., Chen, Y., Ning, Y.-M., Riggs, D. L., Fletterick, R. J., Guy, R. K., Trepel, J. B., Neckers, L. M., and Cox, M. B. (2011) Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 108, 11878-11883
62. Riggs, D. L., Cox, M. B., Tardif, H. L., Hessling, M., Buchner, J., and Smith, D. F. (2007) Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling. Mol. Cell Biol. 27, 8658-8669
63. Elo, J. P., Kvist, L., Leinonen, K., Isomaa, V., Henttu, P., Lukkarinen, O., and Vihko, P. (1995) Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J. Clin. Endocrinol. Metab. 80, 3494-3500
64. Wong, H. Y., Hoogerbrugge, J. W., Pang, K. L., van Leeuwen, M., van Royen, M. E., Molier, M., Berrevoets, C. A., Dooijes, D., Dubbink, H. J., van de Wijngaart, D. J., Wolffenbuttel, K. P., Trapman, J., Kleijer, W. J., Drop, S. L., Grootegoed, J. A., and Brinkmann, A. O. (2008) A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome: increased NH2-/COOH-terminal domain interaction and TIF2 co-activation. Mol. Cell Endocrinol. 292, 69-78
65. Yong, E. L., Ng, S. C., Roy, A. C., Yun, G., and Ratnam, S. S. (1994) Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet 344, 826-827 (Pubitemid 24283983)
66. Buchanan, G., Yang, M., Harris, J. M., Nahm, H. S., Han, G., Moore, N., Bentel, J. M., Matusik, R. J., Horsfall, D. J., Marshall, V. R., Greenberg, N. M., and Tilley, W. D. (2001) Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Mol. Endocrinol. 15, 46-56 (Pubitemid 32156040)
67. Shi, X. B., Ma, A. H., Xia, L., Kung, H. J., and de Vere White, R. W. (2002) Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res. 62, 1496-1502 (Pubitemid 34407813)
68. Cai, C., He, H. H., Chen, S., Coleman, I., Wang, H., Fang, Z., Chen, S., Nelson, P. S., Liu, X. S., Brown, M., and Balk, S. P. (2011) Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell 20, 457-471
69. Ma, C., Yoshioka, M., Boivin, A., Gan, L., Takase, Y., Labrie, F., and St-Amand, J. (2009) Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo. Prostate 69, 293-316
70. Zeiner, M., Niyaz, Y., and Gehring, U. (1999) The hsp70-associating protein Hap46 binds to DNA and stimulates transcription. Proc. Natl. Acad. Sci. U.S.A. 96, 10194-10199 (Pubitemid 29422535)
71. Schmidt, U., Wochnik, G. M., Rosenhagen, M. C., Young, J. C., Hartl, F. U., Holsboer, F., and Rein, T. (2003) Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J. Biol. Chem. 278, 4926-4931 (Pubitemid 36801000)